THP1-Dual™ KO-TREX1 Cells
Product | Unit size | Cat. code | Docs. | Qty. | Price | |
---|---|---|---|---|---|---|
THP1-Dual™ KO-TREX1 Cells Human THP-1 Monocytes - TREX1 knockout NF-κB-SEAP and IRF-Lucia Reporter Cells |
Show product |
3-7 x 10e6 cells |
thpd-kotrex
|
|
TREX1 knockout NF-κB-SEAP and IRF-Lucia luciferase reporter monocytes
Signaling pathways in THP1-Dual™ KO-TREX1 Cells
THP1-Dual™ KO-TREX1 cells were generated from THP1-Dual™ cells by stable biallelic knockout of the TREX1 gene. Human THP1 monocytes or derived macrophages are a common cellular model to study DNA sensing as they naturally express all cytosolic DNA sensors identified so far (except DAI). THP1-Dual™ KO-TREX1 cells feature two inducible reporter genes allowing the concomitant study of the IRF and NF-κB pathways, by monitoring the Lucia luciferase and SEAP (secreted embryonic alkaline phosphatase) activities, respectively.
TREX1 (three prime repair exonuclease 1) is a major cellular 3'->5' exonuclease that plays a crucial role in maintaining immune homeostasis [1,2].
Key features:
- Biallelic knockout of the TREX1 gene
- Functionally validated with a selection of PRR ligands and cytokines
- Readily assessable Lucia luciferase and SEAP reporter activities
Applications:
- Study of IRF and NF-kB-dependent TREX1 signaling pathways
- Screening of interactions between TREX1 and other signaling protein
- Study the role of TREX1 in innate immunity
1. Kavanagh D. et al., 2008. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle. 7(12):1718-25.
2. Hasan M. & Yan N., 2014. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases. Front Microbiol. 5:193.
Specifications
Growth medium: RPMI 1640, 2 mM L-glutamine, 25 mM HEPES, 10% heat-inactivated fetal bovine serum, Pen-Strep (100 U/ml-100 μg/ml), 100 μg/ml Normocin™.
Antibiotic resistance: Blasticidin, Zeocin®
Quality control:
- Biallelic TREX1 gene knockout has been verified by PCR, western blot, sequencing and functional assays.
- The stability of this cell line for 20 passages following thawing has been verified.
- THP1-Dual™ KO-TREX1 cells are guaranteed mycoplasma-free.
This product is covered by a Limited Use License (See Terms and Conditions).
Back to the topContents
- 1 vial of THP1-Dual™ KO-TREX1 cells (3-7 x 106 cells) in freezing medium
- 1 ml of Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasmas, bacteria and fungi.
- 1 ml of Zeocin® (100 mg/ml)
- 1 ml of Blasticidin (10 mg/ml)
- 1 tube of QUANTI-Luc™ 4 Reagent, a Lucia luciferase detection reagent (sufficient to prepare 25 ml)
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
Shipped on dry ice (Europe, USA, Canada, and some areas in Asia)
Back to the topDetails
TREX1 (also known as DNase III) is a major DNA-sensor nuclease in the cytoplasm.
The primary role of TREX1 is to target cellular DNA originating from aberrant replication and recombination [1]. TREX1 is bound to the ER (endoplasmic reticulum) and is able to degrade both single-stranded and double-stranded DNA as well as single-strand RNA. As a result, it blocks the activation of the cGAS-STING pathway, and thus dampening the nucleic acid sensor response. Therefore, it is thought to be a negative regulator of interferon (IFN) signaling preventing autoimmune diseases. Its acidic counterpart, DNase2, shares the same function, but is located in the lysosomes [2].
However, TREX1 function also promotes protumor and -viral responses by degrading tumor- or virus-derived DNA that would otherwise stimulate the cGAS-STING pathway and elicit an immune response [2-3]. Unlike SAMHD1, another enzyme with nuclease activity, TREX1 boosts HIV-1 infection [4]. Mutations in TREX1 have been associated with a variety of disorders, such as the Aicardi–Goutières syndrome, Systemic Lupus Erythematosus or hereditary vascular retinopathy [1-4].
1. Kavanagh D. et al., 2008. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle. 7(12):1718-25.
2. Baris, Adrian M et al., 2021. “Nucleic Acid Sensing in the Tumor Vasculature.” Cancers vol. 13,17 4452.
3. Hemphill et al., 2021. TREX1 as a Novel Immunotherapeutic Target. Front Immunol. Apr 1;12:660184.
4. Hasan M. & Yan N., 2014. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases. Front Microbiol. 5:193